NASDAQ •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/12/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization315.59 mln
Earnings Date08/05/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-3.14
Reliable
1-Year Forecast
12.50
Downside risk
Relative Strength
81
/ 100
Strongly outperforming
Debt / Equity
0.01
Debt-free
ROE
-7.29
Negative
Business Description
Amarin Corporation plc is an Ireland-based pharmaceutical company focused on developing and selling treatments for heart and cardiovascular conditions across the United States, Europe, and other markets. Its main product, VASCEPA, is a prescription omega-3 medication that helps lower dangerously high triglyceride levels in adult patients when used alongside a controlled diet. The company distributes its products through wholesale and retail pharmacy networks, and works with Japan's Mochida Pharmaceutical to expand the use of VASCEPA's key active ingredient in new treatments. Founded in 1989 and originally known as Ethical Holdings plc, the company adopted its current name in 1999.
